- call +1-201-465-4211
- email sales@mrinsights.biz
Genetic modification of humans via gene therapy is becoming a treatment option for diseases ranging from rare metabolic disorders to cancer.
Scope of the Report:
The global Genetic Modification Therapies market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Genetic Modification Therapies.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Genetic Modification Therapies market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Genetic Modification Therapies market by product type and applications/end industries.
Market Segment by Companies, this report covers
4D Molecular Therapeutics
Abeona Therapeutics
Allergan
American Gene Technologies
Merck Millipore
AbbVie
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Gene Therapies
Genetically Modified Cell Therapies
RNA Therapies
Gene Editing
Market Segment by Applications, can be divided into
Hospitals
Diagnostics and Testing Laboratories
Academic and Research Organizations
Others
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Genetic Modification Therapies Market Overview
1.1 Product Overview and Scope of Genetic Modification Therapies
1.2 Classification of Genetic Modification Therapies by Types
1.2.1 Global Genetic Modification Therapies Revenue Comparison by Types (2019-2024)
1.2.2 Global Genetic Modification Therapies Revenue Market Share by Types in 2018
1.2.3 Gene Therapies
1.2.4 Genetically Modified Cell Therapies
1.2.5 RNA Therapies
1.2.6 Gene Editing
1.3 Global Genetic Modification Therapies Market by Application
1.3.1 Global Genetic Modification Therapies Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospitals
1.3.3 Diagnostics and Testing Laboratories
1.3.4 Academic and Research Organizations
1.3.5 Others
1.4 Global Genetic Modification Therapies Market by Regions
1.4.1 Global Genetic Modification Therapies Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Genetic Modification Therapies Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Genetic Modification Therapies Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Genetic Modification Therapies Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Genetic Modification Therapies Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Genetic Modification Therapies Status and Prospect (2014-2024)
1.5 Global Market Size of Genetic Modification Therapies (2014-2024)
2 Manufacturers Profiles
2.1 4D Molecular Therapeutics
2.1.1 Business Overview
2.1.2 Genetic Modification Therapies Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 4D Molecular Therapeutics Genetic Modification Therapies Revenue, Gross Margin and Market Share (2017-2018)
2.2 Abeona Therapeutics
2.2.1 Business Overview
2.2.2 Genetic Modification Therapies Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Abeona Therapeutics Genetic Modification Therapies Revenue, Gross Margin and Market Share (2017-2018)
2.3 Allergan
2.3.1 Business Overview
2.3.2 Genetic Modification Therapies Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Allergan Genetic Modification Therapies Revenue, Gross Margin and Market Share (2017-2018)
2.4 American Gene Technologies
2.4.1 Business Overview
2.4.2 Genetic Modification Therapies Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 American Gene Technologies Genetic Modification Therapies Revenue, Gross Margin and Market Share (2017-2018)
2.5 Merck Millipore
2.5.1 Business Overview
2.5.2 Genetic Modification Therapies Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Merck Millipore Genetic Modification Therapies Revenue, Gross Margin and Market Share (2017-2018)
2.6 AbbVie
2.6.1 Business Overview
2.6.2 Genetic Modification Therapies Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 AbbVie Genetic Modification Therapies Revenue, Gross Margin and Market Share (2017-2018)
3 Global Genetic Modification Therapies Market Competition, by Players
3.1 Global Genetic Modification Therapies Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Genetic Modification Therapies Players Market Share
3.2.2 Top 10 Genetic Modification Therapies Players Market Share
3.3 Market Competition Trend
4 Global Genetic Modification Therapies Market Size by Regions
4.1 Global Genetic Modification Therapies Revenue and Market Share by Regions
4.2 North America Genetic Modification Therapies Revenue and Growth Rate (2014-2019)
4.3 Europe Genetic Modification Therapies Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Genetic Modification Therapies Revenue and Growth Rate (2014-2019)
4.5 South America Genetic Modification Therapies Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Genetic Modification Therapies Revenue and Growth Rate (2014-2019)
5 North America Genetic Modification Therapies Revenue by Countries
5.1 North America Genetic Modification Therapies Revenue by Countries (2014-2019)
5.2 USA Genetic Modification Therapies Revenue and Growth Rate (2014-2019)
5.3 Canada Genetic Modification Therapies Revenue and Growth Rate (2014-2019)
5.4 Mexico Genetic Modification Therapies Revenue and Growth Rate (2014-2019)
6 Europe Genetic Modification Therapies Revenue by Countries
6.1 Europe Genetic Modification Therapies Revenue by Countries (2014-2019)
6.2 Germany Genetic Modification Therapies Revenue and Growth Rate (2014-2019)
6.3 UK Genetic Modification Therapies Revenue and Growth Rate (2014-2019)
6.4 France Genetic Modification Therapies Revenue and Growth Rate (2014-2019)
6.5 Russia Genetic Modification Therapies Revenue and Growth Rate (2014-2019)
6.6 Italy Genetic Modification Therapies Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Genetic Modification Therapies Revenue by Countries
7.1 Asia-Pacific Genetic Modification Therapies Revenue by Countries (2014-2019)
7.2 China Genetic Modification Therapies Revenue and Growth Rate (2014-2019)
7.3 Japan Genetic Modification Therapies Revenue and Growth Rate (2014-2019)
7.4 Korea Genetic Modification Therapies Revenue and Growth Rate (2014-2019)
7.5 India Genetic Modification Therapies Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Genetic Modification Therapies Revenue and Growth Rate (2014-2019)
8 South America Genetic Modification Therapies Revenue by Countries
8.1 South America Genetic Modification Therapies Revenue by Countries (2014-2019)
8.2 Brazil Genetic Modification Therapies Revenue and Growth Rate (2014-2019)
8.3 Argentina Genetic Modification Therapies Revenue and Growth Rate (2014-2019)
8.4 Colombia Genetic Modification Therapies Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Genetic Modification Therapies by Countries
9.1 Middle East and Africa Genetic Modification Therapies Revenue by Countries (2014-2019)
9.2 Saudi Arabia Genetic Modification Therapies Revenue and Growth Rate (2014-2019)
9.3 UAE Genetic Modification Therapies Revenue and Growth Rate (2014-2019)
9.4 Egypt Genetic Modification Therapies Revenue and Growth Rate (2014-2019)
9.5 Nigeria Genetic Modification Therapies Revenue and Growth Rate (2014-2019)
9.6 South Africa Genetic Modification Therapies Revenue and Growth Rate (2014-2019)
10 Global Genetic Modification Therapies Market Segment by Type
10.1 Global Genetic Modification Therapies Revenue and Market Share by Type (2014-2019)
10.2 Global Genetic Modification Therapies Market Forecast by Type (2019-2024)
10.3 Gene Therapies Revenue Growth Rate (2014-2024)
10.4 Genetically Modified Cell Therapies Revenue Growth Rate (2014-2024)
10.5 RNA Therapies Revenue Growth Rate (2014-2024)
10.6 Gene Editing Revenue Growth Rate (2014-2024)
11 Global Genetic Modification Therapies Market Segment by Application
11.1 Global Genetic Modification Therapies Revenue Market Share by Application (2014-2019)
11.2 Genetic Modification Therapies Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2014-2019)
11.4 Diagnostics and Testing Laboratories Revenue Growth (2014-2019)
11.5 Academic and Research Organizations Revenue Growth (2014-2019)
11.6 Others Revenue Growth (2014-2019)
12 Global Genetic Modification Therapies Market Size Forecast (2019-2024)
12.1 Global Genetic Modification Therapies Market Size Forecast (2019-2024)
12.2 Global Genetic Modification Therapies Market Forecast by Regions (2019-2024)
12.3 North America Genetic Modification Therapies Revenue Market Forecast (2019-2024)
12.4 Europe Genetic Modification Therapies Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Genetic Modification Therapies Revenue Market Forecast (2019-2024)
12.6 South America Genetic Modification Therapies Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Genetic Modification Therapies Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Genetic Modification Therapies Picture
Table Product Specifications of Genetic Modification Therapies
Table Global Genetic Modification Therapies and Revenue (Millio
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
